Genetic polymorphisms influencing arsenic metabolism: Evidence from Argentina

Environmental Health Perspectives

Volumn 115, Issue 4, 2007, Pages 599-605

  Engström, Karin Schläwicke ^a   Broberg, Karin ^a   Concha, Gabriela ^b   Nermell, Barbro ^c   Warholm, Margareta ^c   Vahter, Marie ^c  

^a LUND UNIVERSITY   (Sweden)

^b NATIONAL FOOD ADMINISTRATION   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

Arsenic; AS3MT; GSTM1; GSTO1; GSTT1; Metabolism; Methylation; MTHFR; MTR; Polymorphisms

Indexed keywords

ARSENIC; DRINKING WATER; GLUTATHIONE TRANSFERASE; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1; METHYLTRANSFERASE;

ADOLESCENT; ADULT; AGED; ARGENTINA; ARTICLE; ENVIRONMENTAL EXPOSURE; FEMALE; GENE DELETION; GENE FREQUENCY; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HOMOZYGOTE; HUMAN; METABOLISM; METABOLITE; MULTIVARIATE ANALYSIS; NUCLEOTIDE SEQUENCE; PREGNANCY; PRIORITY JOURNAL; URINE; WILD TYPE;

ADOLESCENT; ADULT; AGED; ARGENTINA; ARSENIC; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL POLLUTANTS; ENZYMES; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; WATER SUPPLY;

EID: 34247104651     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.9734     Document Type: Article

References (56)

1. Barrett JC, Fry B, Maller J, Daly MJ. 2005, Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21:263-265.
2. Chen YC, Guo YL, Su HJ, Hsueh YM, Smith T J, Ryan LM, et al. 2003a. Arsenic methylation and skin cancer risk in southwestern Taiwan. J Occup Environ Med 45:241-248.
3. Chen YC, Su HJ, Guo YL, Hsueh YM, Smith TJ, Ryan LM, et al. 2003b. Arsenic methylation and bladder cancer risk in Taiwan. Cancer Causes Control 14:303-310.
4. Chiou HY, Hsueh YM, Hsieh LL, Hsu LI, Hsu YH, Hsieh FI, et al. 1997. Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan. Mutat Res 386:197-207.
5. Chung JS, Kalman DA, Moore LE, Kosnett MJ, Arroyo AP, Beeris M, et al. 2002. Family correlations of arsenic methylation patterns in children and parents exposed to high concentrations of arsenic in drinking water. Environ Health Perspect 110:729-733.
6. Concha G. 2001. Metabolism of Inorganic Arsenic and Biomarkers of Exposure [PhD Thesis]. Stockholm:Institute of Environmental Medicine, Division of Metals and Health, Karolinska Institutet.
7. Concha G, Nermell B, Vahter M. 1998a. Metabolism of inorganic arsenic in children with chronic high arsenic exposure in northern Argentina. Environ Health Perspect 106:355-359.
8. Concha G, Nermell B, Vahter M. 2006. Spatial and temporal variations in arsenic exposure via drinking water in northern Argentina. J Health Popul Nutr 24:317-326. Available: http://202.136.7.26/images/ jhpn243_Spatial-and-Temporal.pdf [accessed 27 February 2007].
9. Concha G, Vogler G, Lezcano O, Nermell B, Vahter M. 1998b. Exposure to inorganic arsenic metabolites during early human development. Toxicol Sci 44:185-190.
10. Crecelius E, Yager J. 1997. Intercomparison of analytical methods for arsenic speciation in human urine. Environ Health Perspect 105:650-653.
11. Del Razo LM, Garcia-Vargas GG, Vargas H, Albores A, Gonsebatt ME, Montero R, et al. 1997. Altered profile of urinary arsenic metabolites in adults with chronic arsenicism. A pilot study. Arch Toxicol 71:211-217.
12. Drobna Z, Waters SB, Walton FS, LeCluyse EL, Thomas DJ, Styblo M. 2004. Interindividual variation in the metabolism of arsenic in cultured primary human hepatocytes. Toxicol Appl Pharmacol 201:166-177.
13. Dulout FN, Grillo CA, Seoane AI, Maderna CR, Nilsson R, Vahter M, et al. 1996. Chromosomal aberrations in peripheral blood lymphocytes from native Andean women and children from northwestern Argentina exposed to arsenic in drinking water. Mutat Res 370:151-158.
14. Figueroa LT, Razmilic BB, González MU. 1992. Corporal distribution of arsenic in mummied bodies owned to an arsenical habitat. In: International Seminar Proceedings: Arsenic in the Environment and Its Incidence on Health (Sancha AM, ed). Santiago, Chile:Universidad de Chile, Facultad de Ciencias Fisicas y Matematicas, 77-82.
15. Frosst P, Blom HJ, Milos R, Goyette P, Sheppard CA, Matthews RG, et al. 1995. A candidate genetic risk factor for vascular disease: a common mutation in methylene-tetrahydrofolate reductase. Nat Genet 10:111-113.
16. Hou SM, Lambert B, Hemminki K. 1995. Relationship between hprt mutant frequency, aromatic DNA adducts and genotypes for GSTM1 and NAT2 in bus maintenance workers. Carcinogenesis 16:1913-1917.
17. International Agency for Research on Cancer. 2004. Some Drinking-water Disinfectants and Contaminants, including Arsenic. IARC Monog Eval Carcinog Risk Hum 84.
18. Klerk M, Lievers KJ, Kluijtmans LA, Blom HJ, den Heijer M, Schouten EG, et al. 2003. The 2756A>G variant in the gene encoding methionine synthase: its relation with plasma homocysteine levels and risk of coronary heart disease in a Dutch case-control study. Thromb Res 110:87-91.
19. Leclerc D, Campeau E, Goyette P, Adjalla CE, Christensen B, Ross M, et al. 1996. Human methionine synthase: cDNA cloning and identification of mutations in patients of the cblG complementation group of folate/ cobalamin disorders. Hum Mol Genet 5:1867-1874.
20. Lin J, Spitz MJ, Wang Y, Schabath MB, Gorlov IP, Hernandez LM, et al. 2004. Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study. Carcinogenesis 25:1639-1647.
21. Lindberg AL, Goessler W, Gurzau E, Koppova K, Rudnai P, Kumar R, et al. 2006. Arsenic exposure in Hungary, Romania and Slovakia. J Environ Monit 8:203-208.
22. Lindberg A-L, Goessler W, Grandér M, Nermell B, Vahter M. 2007. Evaluation of the three most commonly used analytical methods for determination of inorganic arsenic and its metabolites in urine. Toxicol Lett 168:310-318; doi:10.1016/j.toxlet.2006.10.028 [Online 16 November 2006].
23. Mäki-Paakkanen J, Kurttio P, Paldy A, Pekkanen J. 1998. Association between the clastogenic effect in peripheral lymphocytes and human exposure to arsenic through drinking water. Environ Mol Mutagen 32:301-313.
24. Marafante E, Vahter M. 1984. The effect of methyltransferase inhibition on the metabolism of [74As]arsenite in mice and rabbits. Chem Biol Interact 50:49-57.
25. Marafante E, Vahter M, Envall J. 1985. The role of the methylation in the detoxication of arsenate in the rabbit. Chem Biol Interact 56:225-238.
26. Marcos R, Martinez V, Hernandez A, Creus A, Sekaran C, Tokunaga H, et al. 2006. Metabolic profile in workers occupationally exposed to arsenic: role of GST polymorphisms. J Occup Environ Med 48:334-341.
27. Marnell LL, Garcia-Vargas GG, Chowdhury UK, Zakharyan RA, Walsh B, Avram MD, et al. 2003. Polymorphisms in the human monomethylarsonic acid (MMA V) reductase/hGST01 gene and changes in urinary arsenic profiles. Chem Res Toxicol 16:1507-1513.
28. Mazumder DN, Steinmaus C, Bhattacharya P, von Ehrenstein OS, Ghosh N, Gotway M, et al. 2005. Bronchiectasis in persons with skin lesions resulting from arsenic in drinking water. Epidemiology 16:760-765.
29. Meza MM, Yu L, Rodriguez YY, Guild M, Thompson D, Gandolfi AJ, et al. 2005. Developmentally restricted genetic determinants of human arsenic metabolism: association between urinary methylated arsenic and CYT19 polymorphisms in children. Environ Health Perspect 113:775-781.
30. Miller SA, Dykes DD, Polesky HF. 1988. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215.
31. NCBI (National Center for Biotechnology Information). 2006a. Nucleotide Database. Available: http://www.ncbi.nlm.nih.gov/entrez/ query.fcgi?db=Nucleotide [accessed 10 November 2006].
32. NCBI (National Center for Biotechnology Information). 2006b. SNP Database. Available: http://www.ncbi.nlm.nih.gov/SNP [accessed 10 November 2006].
33. NCBI (National Center for Biotechnology Information). 2006c. UniGene Database. Available: http://www.ncbi.nlm.nih.gov/entrez/ query.fcgi?db=unigene [accessed 10 November 2006].
34. NCI (National Cancer Institute). 2006. SNP500 Cancer Database. Available: http://snp500cancer.nci.nih.gov [accessed 10 November 2006].
35. Nesnow S, Roop BC, Lambert G, Kadiiska M, Mason RP, Cullen WR, et al. 2002. DNA damage induced by methylated trivalent arsenicals is mediated by reactive oxygen species. Chem Res Toxicol 12:1627-1634.
36. NRC (National Research Council). 2001. Arsenic in Drinking Water: 2001 Update. Washington DC:National Academy Press.
37. Núñez ALN, Hill HG, Martinez AL. 1991. Guía Museo Arqueológico, Universidad Católica del Norte Chile. San Pedro de Atacama (II Regíon): Instituto de Investigaciones Arqueológicas y Museo RP. Gustavo Le Paige SJ. Antofagasta, Chile:Universidad Católica del Norte Chile.
38. Pemble S, Schroeder KR, Spencer SR, Meyer DJ, Hallier E, Bolt HM, et al. 1994. Glutathione S-transferase theta (GSTT1): cDNA cloning and the characterization of a genetic polymorphism. Biochem J 15:271-276.
39. Rahman M, Vahter M, Sohel N, Yunus M, Wahed MA, Streatfield PK, et al. 2006. Arsenic exposure and age- and sex-specific risk for skin lesions: a population-based case - referent study in Bangladesh. Environ Health Perspect 114:1847-1852.
40. Smith AH, Arroyo AP, Mazumder DN, Kosnett MJ, Hernandez AL, Beeris M, et al. 2000. Arsenic-induced skin lesions among Atacameno people in northern Chile despite good nutrition and centuries of exposure. Environ Health Perspect 108:617-620.
41. Stead LM, Briosnan JT, Brosnan ME, Vance De, Jacobs RL. 2006. Is it time to reevaluate methyl balance in humans? Am J Clin Nutr 83:5-10.
42. Steinmaus C, Bates MN, Yuan Y, Kalman D, Atallah R, Rey DA, et al. 2006. Arsenic methylation and bladder cancer risk in case-control studies in Argentina and the United States. J Occup Environ Med 48:478-488
43. Styblo M, Del Razo LM, Vega L, Germolec DR, LeCluyse EL, Hamilton GA, et al. 2000. Comparative toxicity of trivalent and pentavalent inorganic and methylated arsenicals in rat and human cells. Arch Toxicol 74:289-299.
44. Tanaka-Kagawa T, Jinno H, Hasegawa T, Makino Y, Seko Y, Hanioka N, et al. 2003. Functional characterization of two variant human GSTO 1-1s (Ala140Asp and Thr217Asn) Biochem Biophys Res Commun 301:516-520.
45. Tseng CH, Huang YK, Huang YL, Chung CJ, Yang MH, Chen CJ, et al. 2005. Arsenic exposure, urinary arsenic speciation, and peripheral vascular disease in blackfoot disease-hyperendemic villages in Taiwan. Toxicol Appl Pharmacol 206:299-308.
46. Vahter M. 2000. Genetic polymorphism in the biotransformation of inorganic arsenic and its role in toxicity. Toxicol Lett 112-113:209-217.
47. Vahter M. 2002. Mechanisms of arsenic biotransformation. Toxicology 181-182:211-217.
48. Vahter M, Concha G, Nermell B, Nilsson R, Dulout F, Natarajan AT. 1995. A unique metabolism of inorganic arsenic in native Andean women. Eur J Pharmacol 4:455-462.
49. Vahter M, Friberg L, Rahnster B, Nygren A, Nolinder P. 1986. Airborne arsenic and urinary excretion of metabolites of inorganic arsenic among smelter workers. Int Arch Occup Environ Health 57:79-91.
50. Vahter M, Li L, Nermell B, Rahman A, El Arifeen S, Rahman M, et al. 2006. Arsenic exposure in pregnancy: a population-based study in Matlab, Bangladesh. J Health Popul Nutr 24:236-245.
51. Vega L, Styblo M, Patterson R, Cullen W, Wang C, Germolec D. 2001. Differential effects of trivalent and pentavalent arsenicals on cell proliferation and cytokine secretion in normal human epidermal keratinocytes. Toxicol Appl Pharmacol 172:225-232.
52. Wacholder S, Chanock S, Garcia-Closas M, El Ghormli L, Rothman N. 2004. Assessing the probability that a positive report is false: an approach for molecular epidemiology studies. J Natl Cancer Inst 96:434-442.
53. Wood TC, Salavagionne OE, Mukherjee B, Wang L, Klumpp AF, Thomae BA, et al. 2006. Human arsenic methyltransferase (AS3MT) pharmacogenetics: gene resequencing and functional genomics studies. J Biol Chem 281:7364-7373.
54. Yu RC, Hsu KH, Chen CJ, Froines JR. 2000. Arsenic methylation capacity and skin cancer. Cancer Epidemiol Biomarkers Prev 9:1259-1262.
55. Zakharyan RA, Aposhian HV. 1999. Arsenite methylation by methylvitamin B12 and glutathione does not require an enzyme. Toxicol Appl Pharmacol 154:287-291,
56. Zhang Z, Shi Q, Liu Z, Sturgis EM, Spitz MR, Wei Q. 2005. Polymorphisms of methionine synthase and methionine synthase reductase and risk of squamous cell carcinoma of the head and neck: a case-control analysis. Cancer Epidemiol Biomarkers Prev 14:1188-1193.